Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Immunology/Infectious Diseases
Clinical Trials: Hepatitis
A listing of clinical trials currently looking for volunteers to enroll in Hepatitis studies. Click on the closest city to find more detailed information on a research study in your area.
Birmingham : 1220.48.0004 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Birmingham : 1220.48.0045 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Birmingham : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Birmingham : 1220.19.0045 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Birmingham : University Of Alabama At Birmingham Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
View More »
Birmingham : Alabama Updated
Telaprevir in Combination With Peginterferon and Ribavirin in Treatment-experienced Black/African American Subjects.
Dothan : Digestive Health Specialists Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Dothan : 1220.48.0050 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Dothan : Digestive Health Specialists Updated
Gilead Sustained Virologic Response (SVR) Registry
Hoover : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Montgomery : Alabama Liver & Digestive Specialists (Alds) Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Montgomery : Alabama Liver & Digestive Specialists (Alds) Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Phoenix :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Phoenix : Mayo Clinic Hospital Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Tucson : University of Arizona
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
North Little Rock : 1220.48.0091 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Anaheim : Advanced Clinical Research Institute
Hepatitis C research study for Latino and non-Latino patients who are treatment Naïve.
View More »
Anaheim : Advanced Clinical Research Institute, LLC Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Anaheim : Advanced Clinical Research Institute, LLC Updated
Gilead Sustained Virologic Response (SVR) Registry
Anaheim : Advanced Clinical Res Inst Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Bakersfield : 1220.48.0008 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Bakersfield : The Office of Dr. Franco Antonio Felizarta, M.D.
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Bakersfield : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Bakersfield : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Beverly Hills : California Liver Institute Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Beverly Hills : California Updated
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Beverly Hills : California Liver Institute Updated
Gilead Sustained Virologic Response (SVR) Registry
Beverly Hills : California Liver Institute
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Chula Vista : 1220.48.0019 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Chula Vista : GSK Investigational Site
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Coronado : 1220.48.0010 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Coronado : SCTI Research Foundation Liver Center
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Coronado : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Coronado : Southern California Liver Centers Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Coronado : Southern California Liver Centers Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Costa Mesa : West Coast Clinical Trials, LLC
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Davis : University of California, Davis
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Garden Grove : Sc Clinical Research, Inc. Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
La Jolla : 1220.48.0033 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
La Jolla : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
La Mesa : 1220.48.0035 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
La Mesa : Updated
Phase 3 Study of PSI-7977 and Ribavirin
La Mesa : GSK Investigational Site
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Los Angeles : California Liver Institute Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Los Angeles : 1220.48.0011 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Los Angeles : 1220.48.0100 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Los Angeles : Site Reference ID/Investigator# 59130
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Los Angeles : AIDS Research Alliance
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Los Angeles : Axis Clinical Trials Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Los Angeles : Health Care Consultants
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
Los Angeles :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Los Angeles : California Liver Institute Updated
Gilead Sustained Virologic Response (SVR) Registry
Los Angeles : Axis Clinical Trials
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Los Angeles : UCLA Medical Center
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Los Angeles : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Los Angeles :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Los Angeles : Asian Pacific Liver Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Los Angeles : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Oakland : Alameda County Medical Center
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Oceanside : 1220.48.0018 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Palm Desert : 1220.19.0007 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Palm Springs : Desert Medical Group Inc. Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Palo Alto :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Palo Alto : Stanford University Medical Center,750 Welch Road, Ste. 210
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Poway : 1220.48.0059 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Sacramento : Investigational site Updated
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
Sacramento : University of California
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Sacramento : University of California Davis Research
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Sacramento :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Sacramento : University Of California, Davis Medical Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Sacramento : University Of California Davis Medical Center Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Sacramento : UC Davis Medical Center,4150 V Street Suite #3100,
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Sacramento :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
San Diego : Medical Associates Research Group, Inc. Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
San Diego : 1220.48.0037 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
San Diego : Site Reference ID/Investigator# 43565
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
San Diego : Medical Associates Research Group, Inc Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
San Diego : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
San Diego : Novatis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
San Diego : Medical Associates Research Group, Inc. Updated
Gilead Sustained Virologic Response (SVR) Registry
San Diego : Medical Associates Research Group
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
San Diego : Research and Education, Inc., 4141 Fairmont Ave. Suite 201A
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
San Diego : Updated
Phase 3 Study of PSI-7977 and Ribavirin
San Diego :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
San Diego : Research And Education, Inc. Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
San Diego : Samrang Schimelpfenig, Research and Education Inc
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
San Diego : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
San Francisco : Investigational site Updated
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
San Francisco : University Of California, San Francisco Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
San Francisco : Dr. Philip Rosenthal Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
San Francisco : UCSF - San Fancisco General Hospital
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
San Francisco : Updated
Phase 3 Study of PSI-7977 and Ribavirin
San Francisco :
Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
San Francisco :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
San Francisco : Kaiser Permanente Medical Center Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
San Francisco : Quest Clinical Research
Study of SCY-635, Pegasys and Copegus in Hepatitis C
San Jose : San Jose Gastroenterology
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
San Jose : San Jose Gastroenterology
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
San Jose : San Jose Gastroenterology Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
San Jose : San Jose Gastroenterology
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Ventura : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Aurora : University of Colorado Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Aurora :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Aurora : University of Colorado Updated
Gilead Sustained Virologic Response (SVR) Registry
Aurora : University of Colorado Denver
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Aurora : University of Colorado Hospital
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
View More »
Aurora : Transplant Center And Hepatology Clinic, B-154 Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Aurora : University Of Colorado Denver Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Aurora : University Of Colorado Denver & Hospital Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Aurora : University Of Colorado Denver & Hospital Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Denver :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Englewood : South Denver Gastroenterology Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Englewood : 1220.48.0082 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Englewood : South Denver Gastroenterology Updated
Gilead Sustained Virologic Response (SVR) Registry
Englewood : South Denver Gastroenterology
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Englewood : South Denver Gastroenterology
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Englewood : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Hamden : Gastroenterology Center of Connecticut, 2200 Whitney Ave. Suite # 370
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Hartford : Connecticut Children'S Medical Center Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Hartford : Connecticut Children'S Medical Center Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
New Haven : Yale University School Of Medicine Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
New Haven : Yale University School Of Medicine Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Bradenton : University Hepatitis Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Bradenton : 1220.48.0057 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Bradenton :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Bradenton : University Hepatitis Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Bradenton : Bach and Godofsky Infectious Diseases
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection
View More »
Bradenton : Bach and Godofsky Infectious Diseases
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Bradenton : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Bradenton :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
DeLand : Avail Clinical Research
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Fort Lauderdale : 1220.48.0086 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Fort Lauderdale : 1220.48.0078 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Fort Lauderdale : Therafirst Medical Centers
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Fort Lauderdale : 1220.19.0086 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Fort Pierce : Site Reference ID/Investigator# 43584
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Gainesville : University Of Florida Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Gainesville : Site Reference ID/Investigator# 43917
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Gainesville : University Of Florida Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Gainesville : University Of Florida Hepatology Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Hialeah : 1220.48.0054 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Jacksonville : Borland-Groover Clinic Baptist Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Jacksonville : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Jacksonville : Borland-Groover Clinic Baptist Updated
Gilead Sustained Virologic Response (SVR) Registry
Jacksonville : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Jacksonville : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Maitland : Centre for Advanced Gastroenterology
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Miami : Community AIDS Resource Inc dba Care Resource
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Miami : University of Miami / Jackson Memorial Medical Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Orlando : Orlando Clinical Research Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Orlando : Orlando Immunology Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Orlando : 1220.48.0044 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Orlando : 1220.48.0099 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Orlando : Florida Hospital Transplant Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Orlando : Orlando Immunology Center (ACH) Updated
Gilead Sustained Virologic Response (SVR) Registry
Orlando : Orlando Clinical Research Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Orlando : Orlando Clinical Research Center
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection
Orlando : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Orlando : 1220.19.0044 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Orlando :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Orlando : Orlando Immunology Center Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Orlando : Florida Hospital Transplant Center Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Orlando : Orlando Immunology Center Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Orlando : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Orlando : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Palm Harbor : 1220.48.0095 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Palm Harbor : 1220.7.0095 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
South Miami : Miami Research Associates Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
South Miami : Miami Research Associates Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Tampa : University of South Florida Health - HIV Clinical Research Unit
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Tampa : Infectious Disease Research Institute, Inc Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Tampa : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Vero Beach : 1220.19.0004 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Wellington : South Florida Center of Gastroenterology, P.A. Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Wellington : South Florida Center Of Gastroenterology, P.A. Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Wellington : South Florida Center of Gastroenterology, P.A. Updated
Gilead Sustained Virologic Response (SVR) Registry
Wellington : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Wilton Manors : Rowan Tree Medical, P.A.
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Atlanta : Romero, Rene Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Atlanta : Atlanta Gastroenterology Associates Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Atlanta : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Atlanta : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Atlanta : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
View More »
Augusta :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Columbus : 1220.48.0039 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Columbus : 1220.7.0039 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Decatur : Dekalb Gastroenterology Associates Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Decatur : Atlanta Infectious Disease Specialists Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Decatur : 1220.48.0052 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Decatur : Atlanta Infectious Disease Specialists Updated
Gilead Sustained Virologic Response (SVR) Registry
Decatur : Dekalb Gastroenterology Associates Updated
Gilead Sustained Virologic Response (SVR) Registry
Douglasville : American Red Cross
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Marietta : Gastrointestinal Specialists of Georgia, PC Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Marietta :
A Study to Compare the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) to Standard of Care in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Marietta :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Marietta : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Marietta : Gastrointestinal Specialists of Georgia, PC Updated
Gilead Sustained Virologic Response (SVR) Registry
Marietta : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Marietta : Gastoenterstinal Specialist of Georgia, PA
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
Marietta :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Chicago :
A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients , And With Copegus in Interferon Unable And Interferon Intolerant Patients, With Chronic Hepatitis C Genotype 1 (INFORM-SVR)
Chicago :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Chicago : Asian Village Medical Clinic
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
Chicago : University of Chicago
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Chicago : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
View More »
Maywood : Loyola University Medical Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Maywood : Loyola University Medical Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Springfield : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Indianapolis : Indianapolis Gastroenterology Research Foundation
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Inidanapolis : Indiana University School Of Medicine / Riley Hospital Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Vaiparaiso : 1220.48.0062 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Overland Park :
Assessing Single and Multiple Doses of HCV NS5A Inhibitor IDX719 in Healthy and HCV-Infected Subjects
Bowling Green : Graves-Gilbert Clinic Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Bowling Green : Graves-Gilbert Clinic Updated
Gilead Sustained Virologic Response (SVR) Registry
Baton Rouge : Gastroenterology Associates, LLC Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Baton Rouge : 1220.48.0085 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Baton Rouge : 1220.48.0087 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Baton Rouge : Gastroenterology Associates, LLC Updated
Gilead Sustained Virologic Response (SVR) Registry
New Orleans : Tulane University Health Sciences Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
View More »
New Orleans : LSU Gastroenterology/Center for Digestive Diseases
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Shreveport : Site Reference ID/Investigator# 59124
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Annapolis : Site Reference ID/Investigator# 43568
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Baltimore : Johns Hopkins School Of Medicine Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Baltimore : Site Reference ID/Investigator# 55901
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Baltimore : Johns Hopkins School Of Medicine Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Baltimore : Digestive Disease Associates, P.A. Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
View More »
Baltimore : Mercy Medical Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Baltimore : Evelyn Jordan Center
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Baltimore : University of Maryland, School of Medicine
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Baltimore : Mercy Medical Center Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Baltimore : Johns Hopkins Drug Development Unit
Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
Baltimore : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Baltimore : Digestive Disease Associates, PA
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Baltimore : Mercy Medical Center
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Baltimore : Mercy Medical Center Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Baltimore : Mercy Medical Center, Inc. Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Baltimore : Mercy Medical Center Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Baltimore : Mercy Medical Center Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Baltimore : Digestive Disease Associates
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Baltimore : Mercy Medical Center Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Chevy Chase : 1220.48.0067 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Colombia : Gastro Center Of Maryland Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Columbia : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Lutherville : Johns Hopkins University Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Boston : Beth Israel Deaconess Medical Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Boston : Children'S Hospital Boston Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Shah, Uzma Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Children'S Hospital Boston Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Boston : Beth Israel Deaconess Medical Center
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
View More »
Boston : BIDMC
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Boston : Beth Israel Deaconess Medical Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Brockton : Commonwealth Clinical Studies, LLC Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Brockton : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Brockton : Commonwealth Clinical Studies, LLC Updated
Gilead Sustained Virologic Response (SVR) Registry
Brockton : Commonwealth Clinical Studies, LLC
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Burlington : Lahey Clinic Medical Center
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Framingham : 1220.48.0027 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Framingham : 1220.19.0027 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Springfield : 1220.48.0065 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Springfield : The Research Institute Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Springfield : The Research Institute Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Springfield : Claudia T. Martorell, Md Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Worcester : Umass Memorial Medical Center Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Ann Arbor : University Of Michigan Health System Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Detroit : Henry Ford Hospital
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Detroit : Henry Ford Hospital
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Detroit :
Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Detroit : Henry Ford Health System Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
View More »
Detroit : Henry Ford Hospital
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Novi : Henry Ford Med Ctr- Columbus
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
Minneapolis : University Of Minnesota Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Saint Paul : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Jackson : GV Sonny Montgomery VA Medical Center
3 Grams Daily Valacyclovir in Chronic Hepatitis C Infection
Jackson : G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS Updated New
3 Grams Daily Valacyclovir in Chronic Hepatitis C Infection (Phase II)
Tupelo : Digestive Health Specialists Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Tupelo : 1220.48.0023 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Tupelo : Digestive Health Specialists Updated
Gilead Sustained Virologic Response (SVR) Registry
St Louis : Novartis Investigator Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
St. Louis : Bruce Bacon M.D.
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Las Vegas : 1220.48.0046 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Las Vegas : Impact Clinical Trials
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Las Vegas : GSK Investigational Site
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Berlin : Comprehensive Clinical Research
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Camden : 1220.19.0008 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Egg Harbor Township : Site Reference ID/Investigator# 55526
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Egg Harbor Twp : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Hillsborough : ID Care, Inc. Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
View More »
Hillsborough : ID Care, Inc. Updated
Gilead Sustained Virologic Response (SVR) Registry
Hillsborough : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Hillsborough : 1220.19.0009 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Hillsborough : ID Care, Inc.
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Morristown : Research Center at Affiliates in Gastroenterology Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Morristown : Research Center at Affiliates in Gastroenterology Updated
Gilead Sustained Virologic Response (SVR) Registry
Newark : Saint Michael's Medical Center
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Newark :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Newark : 1220.19.0015 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Newark : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Vineland : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Manhasset : Biomedical Research Alliance of New York
Chronic Hepatitis C Genotype 1 and 4 Virus Infection - Adults
New York : Biomedical Research Alliance of New York
Chronic Hepatitis C- Non-Responsive to Prior Interferon Alfa Treatment
View More »
Albany : 1220.19.0011 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Albany : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Bronx : Montefiore Medical Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Bronx : James J Peters Vamc Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Bronx : Bronx Va Medical Center #111f Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Brooklyn : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Durham : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Flushing : Medical Procare, Pllc Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Flushing : Office Of Sing Chan Md Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Flushing : 132-21 41 Ave. Suite 1A
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Forest Hills : Columbia University College of Physicians & Surgeons
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Great Neck : North Shore University Hospital,255 Community Drive
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Great Neck : North Shore University Hospital
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Manhasset : North Shore University Hospital
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Manhasset : North Shore University Hospital Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Monticello : Site Reference ID/Investigator# 59133
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Monticello : Upper Delaware Valley Infectious Diseases, Pc Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
New York : Mount Sinai Medical Center Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
New York : 1220.48.0006 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
New York : Mount Sinai School Of Medicine Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
New York : Mount Sinai School of Medicine
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
New York : Bellevue Hospital
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
New York : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
New York :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
New York : Weill Cornell College of Medicine,1305 York Ave. 4th floor #430
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
New York : Weill Cornell Medical College
Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
New York : 1220.19.0006 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
New York : Weill Cornell Medical College of Cornell University, 1305 York Ave. 4th floor
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : Beth Israel Medical Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : New York Univ. Medical Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : New York Presbyterian Hospital: Weill Medical College of Cornell University
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
New York : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Poughkeepsie : Site Reference ID/Investigator# 55532
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Valhalla : New York Medical College
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Yonkers : Westchester Medical Center,Westchester Digestive Disdase Grp
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Asheville : Asheville Gastroenterology Associates, P.A.
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Chapel Hill : University Of North Carolina At Chapel Hill School Of Med Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Chapel Hill : University of North Carolina
Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling
Chapel Hill : University Of North Carolina, Chapel Hill Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Charlotte : Levine Children'S Hospital At Carolinas Medical Center Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
View More »
Charlotte : I.D. Consultants, P.A.
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Charlotte : Carolinas Medical Center Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Charlotte : Carolinas Medical Center Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Charlotte : Charlotte Gastroenterology & Hepatology, Pllc Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Durham : Duke University Medical Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Durham : Duke University Medical Center
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Durham : Duke University Medical Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Durham : Duke University Medical Center
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Durham : Duke University,201 Trent Drive, Orange Zone Basement
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Durham : Duke University Medical Center
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
Durham : Duke University Medical Center
Study of SCY-635, Pegasys and Copegus in Hepatitis C
Fayetteville : Novartis Investigative site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Statesville : Site Reference ID/Investigator# 55542
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Statesville : Carolinas Center For Liver Disease Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Statesville : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Statesville : Carolinas Center For Liver Disease Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Statesville : Carolinas Center For Liver Disease Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Wilmington : Registry Coordinating Center
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Wilmington : Kendle
Ribavirin Pregnancy Registry
Winston-Salem : 1220.48.0077 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Winston-Salem : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Winston-Salem : 1220.19.0021 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Winston-Salem : Wake Forest University Health Sciences
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Cincinnati : University of Cincinnati Medical Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Cincinnati : Site Reference ID/Investigator# 55533
A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Cincinnati : University of Cincinnati Updated
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
Cincinnati : University of Cincinnati Medical Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Cincinnati : 1220.19.0010 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
View More »
Cincinnati : University of Cincinnati
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Cincinnati : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Cleveland : Case Western Reserve,11100 Euclid Avenue
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Tulsa : Options Health Research LLC Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Tulsa : 1220.48.0098 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Tulsa : Options Health Research LLC Updated
Gilead Sustained Virologic Response (SVR) Registry
Tulsa : GSK Investigational Site
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Tulsa : Healthcare Research Consultants Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
View More »
Tulsa : Options Health Research, Llc Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Tulsa : Healthcare Research Consultants Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Tulsa : Options Health Research, Llc Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Tulsa : Options Health Research, Llc Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Clackamas : Kaiser Permanente Sunnybrook Medical Office
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Portland : 1220.48.0058 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Portland : Kaiser Permanente Northwest
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Portland : Oregon Health Science University Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Portland : Oregon Health Science Univ Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
North Wales : Coordinating Location Updated
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)
Philadelphia : Children'S Hospital Of Philadelphia Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Philadelphia : Children'S Hospital Of Philadelphia Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Philadelphia : Hospital Of The University Of Pennsylvania Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Philadelphia : University Of Pennsylvania Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
View More »
Philadelphia : 121 N. 9th Street
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Pittsburgh :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Pittsburgh : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Providence : Rhode Island Hospital Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Providence : University Gastroenterology
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Providence : University Gastroenterology Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Charleston : Medical Univ of South Carolina
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Columbia : South Carlonia Updated
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Germantown : Gastroenterology Center of the MidSouth, P.C. Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Germantown : 1220.48.0030 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Germantown : Gastroenterology Center of the MidSouth, P.C. Updated
Gilead Sustained Virologic Response (SVR) Registry
Germantown : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Germantown : Gastro One Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
View More »
Jackson : 1220.48.0072 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Nashville : The Frist Clinic Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Nashville : Nashville Gastrointestinal Specialists, Inc Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Nashville : 1220.48.0041 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Nashville :
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols.
Nashville :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Nashville : Nashville Gastrointestinal Specialists, Inc Updated
Gilead Sustained Virologic Response (SVR) Registry
Nashville : The Frist Clinic Updated
Gilead Sustained Virologic Response (SVR) Registry
Nashville : Nashville Gastrointestinal Specialists, Inc
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Nashville : Updated
Phase 3 Study of PSI-7977 and Ribavirin
Nashville :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Addison : Southwest Infectious Disease Clinical Research
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Arlington : The North Texas Research Institute Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Arlington : 1220.48.0063 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Arlington : Texas Clinical Research Institute Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Arlington : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
View More »
Arlington : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Arlington : The North Texas Research Institute Updated
Gilead Sustained Virologic Response (SVR) Registry
Arlington : The North Texas Research Institute
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Arlington : The North Texas Research Institute
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Arlington : Texas Clinical Research Institute Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Arlington : The North Texas Research Institute
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Arlington : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Austin : 1220.48.0029 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Austin : 1220.19.0029 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Dallas : 1220.48.0071 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Dallas : University Of Texas Southwestern Medical Center Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Dallas : University of Texas Southwestern Medical Center at Dallas
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Dallas : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Dallas : The Liver Institute
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
Dallas : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Dallas : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Fort Worth : 1220.48.0060 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Fort Worth : 1220.19.0060 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Houston : Kelsey Research Foundation Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Houston : Research Specialists of Texas Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Houston : Texas Children'S Hospital Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Houston : 1220.48.0009 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Houston : Baylor College Of Medicine Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Houston : Research Specialists Of Texas Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Houston : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Houston :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Houston : Kelsey Research Foundation Updated
Gilead Sustained Virologic Response (SVR) Registry
Houston : Research Specialists of Texas Updated
Gilead Sustained Virologic Response (SVR) Registry
Houston : Research Specialists of Texas
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Houston : Research Specialists of Texas
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Houston : Houston Gastroenterology Clinic
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
Houston : St. Luke'S Episcopal Hospital - Baylor College Of Medicine Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Houston : Liver Associates Of Texas Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Houston : Liver Associates of Texas,
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Houston : Advanced Liver Therapies at St. Luke's Episcopal Hospital
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Houston : Kelsey Research Foundation
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Houston : Research Specialists of Texas
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Houston : Liver Associates Of Texas Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Houston : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Kansas : University of Kansas Medical Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Plano : Digestive Health Associates of Texas
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
San Antonio : Alamo Medical Research, Ltd. Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
San Antonio : 1220.48.0016 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
San Antonio : Updated
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
San Antonio : Site Reference ID/Investigator# 60999
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-267 and With and Without Ribavirin (RBV) in Treatment-Naïve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
San Antonio : Alamo Medical Research Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
San Antonio : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
San Antonio : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
San Antonio : Alamo Medical Research, Ltd. Updated
Gilead Sustained Virologic Response (SVR) Registry
San Antonio : Alamo Medical Research
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
San Antonio :
Open-Label Hepatic Impairment Study
San Antonio : Updated
Phase 3 Study of PSI-7977 and Ribavirin
San Antonio : 1220.19.0016 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
San Antonio : Alamo Medical Research
Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
San Antonio :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
San Antonio : Alamo Medical Research Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
San Antonio : Alamo Medical Research Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
San Antonio : Alamo Medical Research
Study of SCY-635, Pegasys and Copegus in Hepatitis C
San Antonio : Alamo Medical Research Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
San Antonio : Alamo Medical Research Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
San Antonio : Alamo Medical Research Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
San Antonio : Alamo Medical Research Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
San Antonio : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Salt Lake City : Lifetree Clinical Research Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Salt Lake City : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Salt Lake City : Lifetree Clinical Research Updated
Gilead Sustained Virologic Response (SVR) Registry
Salt Lake City : University of Utah Pediatric Pulmonology, 8th Avenue and C Street
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Salt Lake City :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
View More »
Salt Lake City : University of Utah, 8th Avenue and C Street
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Annandale : 1220.19.0001 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Fairfax : Metropolitan Research Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Fairfax : Inova Fairfax Hospital For Children Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Fairfax : 1220.48.0042 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Fairfax : Metropolitan Research Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
View More »
Fairfax : Novartis Investigator Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Fairfax : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Fairfax : Metropolitan Liver Diseases Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Fairfax : Metropolitan Research
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Fairfax : Metropolitan Liver Diseases Center
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Fairfax : Metropolitan Research Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Fairfax : Metropolitan Research Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Fairfax : Metropolitan Research Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Fairfax : Metropolitan Research Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Fairfax : Metropolitan Research Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Fairfax : Metropolitan Research Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Fairfax : Metropolitan Liver Diseases Center
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Fairfax : Metropolitan Research Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Falls Church : Updated
TMC435HPC2002 - Phase II Trial of TMC435 in Combination With PSI-7977 in Prior G1 Null Responders to Peg-IFN/RBV, Hepatitis C-Infected Patients
Newport News : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Newport News :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Norfolk : Digestive and Liver Disease Specialists Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Norfolk : Updated
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Norfolk : Digestive and Liver Disease Specialists Updated
Gilead Sustained Virologic Response (SVR) Registry
Norfolk : Digestive and Liver Disease Specialists
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Norfolk : Digestive and Liver Disease Specialists
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Richmond : Liver Institute of Virginia, Bon Secours Health System Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Richmond : 1220.48.0026 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Richmond : Mcguire D V A M C Updated
BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Richmond : Liver Institute of Virginia, Bon Secours Health System Updated
Gilead Sustained Virologic Response (SVR) Registry
Richmond : Liver Institute of Virginia, Bon Secours Health System
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Richmond : Call for Information
MK-5172 With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Richmond : 1220.19.0026 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Richmond :
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Richmond : Liver Institute of Virginia, Bon Secours Health System
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Richmond : McGuire Research Institute
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seattle : Virginia Mason Medical Center Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Vancouver :
A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients , And With Copegus in Interferon Unable And Interferon Intolerant Patients, With Chronic Hepatitis C Genotype 1 (INFORM-SVR)
Washington : Walter Reed Army Medical Center
Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV
Madison : Wisconsin
A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
Madison : Dean Clinic Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Madison : Dean Clinic Updated
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Not Been Treated With Standard of Care
Madison : Dean Clinic Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Milwaukee : 1220.48.0073 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Elbasan :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Tirana :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Buenos Aires : CIDEA
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Buenos Aires : Merck Sharp & Dohme (Argentina) Inc.
MK-5172 Administered With Peginterferon and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C (MK-5172-003 AM2)
Bunos Aires : Local Institution Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Rosario : Instituto CAICI
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Rosario : Hospital Provincial del Centenario
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Adelaide : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Adelaide SA : Royal Adelaide Hospital,Dept. of Gastroenterology and Hepatology, North Terrace
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Camperdown : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Canberra : Investigational site Updated
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
Clayton : Monash Medical Centre
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
View More »
Clayton Vic : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Clayton Vic : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Concord : Updated
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Darlinghurst : St Vincents Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Darlinghurst Nsw : Local Institution Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Fitzroy : St Vincent's Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Fremantle : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Fremantle : Fremantle Hospital, B2 Clinic, Alma Street
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Greenslopes : Greenslopes Private Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Heidelberg : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Heidelberg Vic : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Herston :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Herston : Royal Brisbane & Women's Hospital
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Kingswood : Nepean Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Kogarah : St George Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Liverpool : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Melbourne : The Alfred Hospital
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Melbourne :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Melbourne : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Perth : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Sydney :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Westmead : Westmead Hospital
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Westmead Nsw : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Woolloongabba, : Greenslopes Private Hospital,Dept. of Gastroenterology and Hepatology
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Gratwein :
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C, Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy (PEGHOPE)
Graz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Innsbruck :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Innsbruck :
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C, Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy (PEGHOPE)
Klagenfurt :
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C, Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy (PEGHOPE)
View More »
Linz : 1220.48.4303 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Linz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Linz : 1220.7.4303 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Vienna : Merck Sharp & Dohme Gmbh
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Wien : 1220.48.4301 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Wien : 1220.48.4302 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Wien : 1220.48.4304 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Wien :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wien :
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C, Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy (PEGHOPE)
Wien :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Wien : 1220.7.4301 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Wien : 1220.7.4302 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Antwerpen : Updated
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Brugge : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Brussels : GSK Investigational Site
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
Brussels : Updated
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Brussels : Novartis Investigative Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
View More »
Brussels : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Bruxelles : Local Institution Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bruxelles : 1220.48.3201 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Bruxelles : 1220.48.3207 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Bruxelles : GSK Investigational Site
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
Bruxelles : Local Institution Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Bruxelles : Merck Sharp & Dohme B.V.
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Bruxelles :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Bruxelles : Merck Sharp & Dohme B.V.
MK-5172 Administered With Peginterferon and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C (MK-5172-003 AM2)
Bruxelles : 1220.7.3201 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Charleroi :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Edegem : 1220.48.3204 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Gent : 1220.48.3205 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Gent : 1220.7.3205 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Gent : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Haine-saint-paul :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Jette : 1220.48.3206 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Leuven : 1220.48.3202 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Leuven :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Liege :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Liège : 1220.48.3203 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Namur :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Seraing :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Verviers :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Yvoir :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Banja Luka :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Mostar :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Sarajevo :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Tuzla :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Zenica :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Aracajú - SE :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Belém :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Belo Horizonte :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Campinas :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Campo Grande - Ms :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
View More »
Curitiba :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Goiania :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Nova Iguaçu :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Nova Iguaçu :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Porto Alegre : Local Institution Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Porto Velho - Go :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Pouso Alegre :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Recife :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Ribeirão Preto :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Rio de Janeiro :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Rio Grande :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Salvador :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Santo Andre :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Santos :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
São José Do Rio Pr :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Sao Luis :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Sao Paulo :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
São Paulo :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Sco Paulo : Local Institution Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Sorocaba :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Sorocaba :
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Uberaba :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Vitoria :
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Plovdiv : Updated
TMC435-TiDP16-C216 - Phase III Trial of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients
Sofia :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Sofia : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Varna :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Varna : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Ouagadougou 01 : GSK Investigational Site
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
Calgary : 1220.48.1011 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Calgary : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Calgary : University of Calgary, 3330 Hospital Drive NW, Room 1721
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Calgary : Heritage Med Research Clinic, Univ of Calgary
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Calgary : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
View More »
Edmonton : 1220.48.1012 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Edmonton : GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants.
Edmonton : GIRI GI Research Institute
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Hamilton : 1220.48.1013 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Kirkland : Merck Frosst Canada Ltd.
MK-5172 Administered With Peginterferon and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C (MK-5172-003 AM2)
London : London Health Sciences Centre
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Montreal : 1220.48.1010 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Montreal : 1220.48.1014 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Montreal :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Montreal : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Montreal : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Montreal : Immunodeficiency Service Montreal Chest Institute McGill University Health Centre
Trial of Citalopram for the Prevention of Depression
Montréal : Centre hospitalier de l'Université de Montréal
Ribavirin Dose Optimization for the Treatment of Hepatitis C
Ottawa : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Regina : University of Regina
Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
Saskatoon : University of Saskatchewan
Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
Toronto : Local Institution Updated
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Toronto : 1220.48.1006 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Toronto : 1220.48.1005 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Toronto : 1220.48.1015 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Toronto : Local Institution Updated
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Toronto : Biovail Contract Research
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Toronto : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Toronto : Toronto Liver Centre
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Toronto : Toronto Liver Centre
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toronto : Toronto General Hospital
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toronto : Local Institution Updated
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Toronto : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Toronto : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Truro : GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants.
Vancouver : Liver and Intestinal Research Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Vancouver : 1220.48.1001 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Vancouver : 1220.48.1016 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Vancouver : 1220.48.1003 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Vancouver : Liver and Intestinal Research Centre
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Vancouver :
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Vancouver : LAIR Centre
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Vancouver : Pacific Gastroenterology - GI Research Institute
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Vancouver : University of British Columbia
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Vancouver : Liver and Intestinal Research Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Vancouver : GIRI GI Research Institute,770-1190 Hornby Street
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Vancouver : LAIR Centre
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Vancouver : Gastrointestional Research Institute
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Vancouver : Liver and Intestinal Research Centre
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Vancouver : Gordon & Leslie Diamond Health Care Centre
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Victoria : 1220.48.1007 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Victoria :
A Study of RO5024048 in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Winnipeg : University of Manitoba, Health Sciences Center Updated
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Winnipeg : 1220.48.1009 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Winnipeg : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Winnipeg : University of Manitoba, Health Sciences Center Updated
Gilead Sustained Virologic Response (SVR) Registry
Winnipeg : University of Manitoba, Health Sciences Center, John Buhler Research Centre, Liver Diseases Unit
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Winnipeg : The University of Manitoba
Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
Zeidler Ledcore Centre : University of Alberta,Zeidler Ledcore Centre
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Santiago : Merck Sharp & Dohme (I.A.) Corp.
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Beijing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Beijing : Novartis Investigative Site
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B
Beijing : Beijing Ditan Hospital
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
Bejing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chengdu :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
View More »
Chongqing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Guangzhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hang Zhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hangzhou : Yangyida
Therapeutic Hepatitis B Vaccine (Synthesized Peptide εPA-44) Joint Entecavir in Treating Chronic Hepatitis B Patients
Harbin :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hong Kong : Department of Medicine, Queen Mary Hospital
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Jinan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nan Jing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nanjing : Center for Disease Control and Prevention Jiangsu Province
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Peking : Peking University People's Hospital
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
Peking : First Hospital of Peking University
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
Shanghai :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shanghai : Ruijin Hospital, Affiliated to 2nd Medical university
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
Shen Yang :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shen Zhen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shi Jiazhuang :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Urumchi :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wen Zhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Xi'an :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Brno : Fakultni nemocnice Brno
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Praha : Merck Sharp & Dohme IDEA Inc.
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Cairo :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Cairo : Kasr Alaini school of medicne
Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
Giza :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Tanta :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Pärnu :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Tallinn :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Espoo : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Helsinki : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Jarvenpaa : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Kokkola : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Lahti : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
View More »
Oulu : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Pori : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Seinajoki : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Tampere : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Turku : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Vantaa : GSK Investigational Site Updated
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Aix En Provence :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Aix en Provence : Service d'Hépatogastroentérologie et d'endoscopie digestive - CH du Pays d'Aix
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Amiens :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Amiens : Service d'Hépatogastroentérologie - Hôpital Nord
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Angers :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
View More »
Angers : service de medecine A CHU
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Angers : Service d'Hépatologie - Gastroentérologie - Cancérologie digestive - CHU Angers
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Argenteuil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Argenteuil : Service d'Hépatogastroentérologie - CH Victor Dupouy
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Avignon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Besancon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Besançon : Service d'Hépatogastroentérologie - Hôpital Jean Minjoz
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Bobigny :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bobigny : Service d'Hépatogastroentérologie - Hôpital Avicenne
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Bondy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bondy : Hopital Jean Verdier
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Bondy : Hopital Jean Verdier
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
Bondy : Service d' Hépatogastroentérologie - Hôpital Jean Verdier
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Bordeaux :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bourgoin Jallieu :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bourgoin-Jallieu : Cabinet Médical
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Brest : Service d'Hépatogastroentérologie - Hôpital de la Cavale Blanche
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Caen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Caen : Service d'Hépatologie - Gastroentérologie - Nutrition -Hôpital de la Côte de Nacre
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Chambray-lès-tours :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chateauroux : Service d'Hépatogastroentérologie - CH de Chateauroux
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Clamart :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clermont-Ferrand : 1220.48.3314 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Clermont-ferrand :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clermont-Ferrand : Service d'Hépatogastroentérologie - Hotel Dieu
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Clichy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clichy : Beaujon Hospital
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Clichy : Beaujon Hospital
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
Clichy : Hôpital Beaujon
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Clichy : Service d'Hépatogastroentérologie - Hôpital Beaujon
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Clichy : 1241.21.33005 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Clichy : Service Hepatologie- Centre Pierre Abrami
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Clichy Cedex : 1220.48.3301 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Clichy Cedex : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Clichy Cedex : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Clichy Cedex : Local Institution Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Clichy Cedex : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Corbeil-essonnes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Corbeil-Essonnes : Service d'Hépatogastroentérologie - CH Sud Francilien
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Creil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Creteil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Creteil : Hopital Henri Mendor-Service d'HepatoGastroEnterologie
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Creteil : Local Institution Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Creteil : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Creteil Cedex : Local Institution Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Creteil Cedex : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Dijon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Dijon : Service d'Hépatogastroentérologie - Hôpital du Bocage
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Dijon cedex : Service des Maladies Infectieuses CHU
Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients
Dijon cedex : 1220.19.3302 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Grasse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Grenoble Cedex 9 : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Grenoble Cedex 9 : CHU de Grenoble
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Grenoble cédex 9 : 1241.21.33007 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Kremlin Bicêtre : Hopital Kremlin Bicêtre
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Kremlin Bicêtre : Hopital Kremlin Bicêtre
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
La Roche sur Yon : Service d'Hépatogastroentérologie - CH La Roche sur Yon
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
La Roche-Sur-Yon Cedex 9 : Local Institution Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Lagny Sur Marne :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Le Kremlin-bicetre :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Le Kremlin-Bicetre : Service des Maladies du Foie et de l'appareil Digestif - Hôpital de Bicêtre
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Le Mans :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Le Mans : Département d'Hépatogastroentérologie - CH Le Mans
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Lille :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lille : Service d'Hépatogastroentérologie - CHRU - Hôpital Claude Huriez
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Lille Cedex : 1220.48.3311 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Limoges :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Limoges : Unité de Médecine Interne A - Hôpital Dupuytren
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Limoges : Local Institution Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Lyon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lyon : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Lyon : Hôpital Croix-Rousse
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Lyon : Service d'Hépatogastroentérologie - Hotel Dieu
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Lyon : 1220.19.3306 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Lyon : 1241.21.33003 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Lyon : Hôpital de la Croix Rousse, Service Hepatogastro enterologie-endoscopie
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Lyon : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Lyon Cedex 02 : Service d'Hépato-Gastroentérologie Hopital Hôtel-Dieu
Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients
Marseille : Hôpital Saint Joseph, Service d'hépatogastroentérologie
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Marseille :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Marseille : Service d'Hépatogastroentérologie - Hôpital Saint Joseph
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Marseille : 1241.21.33001 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Marseille Cedex 08 : 1220.48.3303 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Marseille Cedex 08 : 1220.19.3303 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Marseille Cedex 08 : Local Institution Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Marseille Cedex 08 : Local Institution Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Marseille Cedex 08 : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Marseille cedex 9 : 1220.19.3304 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Metz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montauban :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montauban : Service d'Hépatogastroentérologie - CH Montauban
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Montelimar : Service d'Hépatogastroentérologie - CH Montélimar
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Montivilliers :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montpellier :
A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C
Montpellier :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montpellier : Service d'Hépatogastroentérologie - Hôpital Saint Eloi
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Montpellier : 1241.21.33002 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Montpellier Cedex 5 : 1220.48.3304 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Montpellier Cedex 5 : Hôpital Saint-Eloi
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Montpellier Cedex 5 : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Montpellier Cedex 5 : Local Institution Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Montpellier Cedex 5 : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Montpellier Cedex 5 : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Mulhouse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nantes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nantes : Service d'Hépatogastroentérologie - Hôpital Nord Laennec
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Nantes : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Nice Cedex 03 : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Nice Cedex 03 : Local Institution Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Nice Cedex 03 : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Nice Cedex 3 : 1220.48.3305 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Nimes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Niort :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Orleans :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Orléans : Service d'Hépatogastroentérologie - Hôpital de la Source
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Orleans Cedex 2 : Local Institution Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Paris : 1220.48.3302 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Paris : 1220.48.3310 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Paris :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Paris : Hôpital Tenon Service des Maladies Infectieuses
ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV
Paris : Hopital Tenon
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Paris : Novartis Investigative Site
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Paris : Service d'Hépatogastroentérologie - Hôpital Cochin
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Paris : Service d'Hépatogastroentérologie - Hôpital La Pitié Salpétrière
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Paris : Service d'Hépatogastroentérologie - Hôpital Necker
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Paris : Service d'Hépatogastroentérologie - Hôpital Tenon
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Paris : 1220.19.3301 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Paris : 1220.19.3305 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Paris : Local Institution Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Paris : 1241.21.33004 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Paris : 1241.21.33008 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Paris : Hopital Tenon- 4 Rue de la Chine
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Paris : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Paris : Hopital Cochin CIC de vaccinologie
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Paris Cedex 10 : Local Institution Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Paris Cedex 12 : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Paris Cedex 12 : Hôpital Saint Antoine
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Paris Cedex 12 : 1220.19.3307 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Paris Cedex 12 : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Paris Cedex 12 : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Paris Cedex 13 : Hôpital La Pitié Salpétrière
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Paris Cedex 13 : Local Institution Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Paris Cedex 13 : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Paris Cedex 14 : Local Institution Updated
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Paris Cedex 14 : Local Institution Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Paris Cedex 14 : Local Institution Updated
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Paris Cedex 14 : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
MK-5172 Administered With Peginterferon and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C (MK-5172-003 AM2)
Perpignan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Pessac :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Pessac : Service d'Hépatogastroentérologie et d'Assistance nutritive - Hôpital Haut-Lévêque
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Pessac : Local Institution Updated
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
Pessac Cedex : 1220.48.3316 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Pessac Cedex : Local Institution Updated
Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Reims :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rennes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rennes : Service d'Hépatogastroentérologie - Hôpital Pontchaillou
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Rennes :
Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients
Rennes Cedex 09 : 1220.48.3315 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Rennes Cedex 9 : Local Institution Updated
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Rennes, 35 : CHU de Rennes,2 rue Henri Le Guilloux
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Rouen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rouen : Service d'Hépatogastroentérologie - CHU Rouen
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Rouen : Service d'Hepatogastroenterologie,1 rue de Germont
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Saint Dizier : Service d'Hépatogastroentérologie - CH Saint Dizier
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Saint Laurent du Var : 1220.48.3312 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Saint Laurent Du Var :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
St Maurice :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Strasbourg :
A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C
Strasbourg :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Strasbourg : Hopital Civil
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Strasbourg : Hopital Civil
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
Strasbourg : Service d'Hépatogastroentérologie, Clinique médicale B - Hôpital Civil
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Strasbourg : Nouvel Hopital Civil , Service d'Hepatogastroenterologie
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toulon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Toulouse : 1220.48.3313 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Toulouse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Toulouse : Service d'Hépatogastroentérologie - Hôpital Purpan
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Toulouse : C.H.U. de Toulouse - Hôpital Purpan
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toulouse Cedex 09 : Local Institution Updated
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Tours : Service d'Hépatogastroentérologie - Hôpital Trousseau
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Vandoeuvre Cedex : 1241.21.33006 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Vandoeuvre les Nancy : Service d'Hépatogastroentérologie - Hôpital Brabois
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Vandoeuvre Les Nancy : Local Institution Updated
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Vandoeuvre-les-nancy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Villejuif Cedex : Centre Hépatobiliaire Paul Brousse
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Berlin : 1220.48.4904 Boehringer Ingelheim Investigational Site
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Berlin : EPIMED - Gesellschaft fuer epidemiologische und klinische Forschung in der Medizin mbH
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Berlin :
A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy
Berlin : Updated
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Berlin :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
View More »
Berlin :
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Berlin : Leber- und Studienzentrum am Checkpoint
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients
Berlin : 1220.19.4902 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Berlin : 1220.19.4921 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Berlin : 1220.7.4902 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Berlin : 1220.7.4904 Boehringer Ingelheim Investigational Site
Pivotal Trial Treatment Experienced Patient Infected With Hepatitis C Virus (HCV) Genotype 1 (GT1)
Berlin : 1241.21.49003 Boehringer Ingelheim Investigational Site
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Berlin : Leberzentrum am Checkpoint
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Charite CVK
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Charite Berlin, Campus Virchow-Klinikum- Augustenburger Platz 1
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Berlin : Updated
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Berlin : Updated
TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients
Bonn : Universitaetsklinikum Bonn, Immunologische Ambulanz HIV
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Bonn : 1220.19.4901 Boehringer Ingelheim Investigational Site
Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Bonn : Uni
